Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2051-5960

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy ; volume:7 ; number:1 ; day:26 ; month:2 ; year:2019 ; pages:1-15 ; date:12.2019
Acta Neuropathologica Communications ; 7, Heft 1 (26.2.2019), 1-15, 12.2019

Creator: You, Yingjian
Perkins, Abigail
Cisternas, Pablo
Muñoz, Braulio
Taylor, Xavier
You, Yanwen
Garringer, Holly J.
Oblak, Adrian L.
Atwood, Brady K.
Vidal, Ruben
Lasagna-Reeves, Cristian A.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s40478-019-0680-z

URN: urn:nbn:de:101:1-2019032419250109518053

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:45 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

You, Yingjian
Perkins, Abigail
Cisternas, Pablo
Muñoz, Braulio
Taylor, Xavier
You, Yanwen
Garringer, Holly J.
Oblak, Adrian L.
Atwood, Brady K.
Vidal, Ruben
Lasagna-Reeves, Cristian A.
SpringerLink (Online service)

Other Objects (12)

Retinal amyloid angiopathy

Cerebral amyloid angiopathy: an update

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

Probable cerebral amyloid angiopathy diagnosed on plain CT

Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy

Retinal amyloid angiopathy

Cerebral amyloid angiopathy: an update

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

Probable cerebral amyloid angiopathy diagnosed on plain CT

Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy

Retinal amyloid angiopathy

Cerebral amyloid angiopathy: an update

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

Probable cerebral amyloid angiopathy diagnosed on plain CT

Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Tau as a mediator of neurotoxicity associated to cerebral amyloid angiopathy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Retinal amyloid angiopathy

Cerebral amyloid angiopathy: an update

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

Probable cerebral amyloid angiopathy diagnosed on plain CT

Probable cerebral amyloid angiopathy diagnosed on plain CT

Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy

Retinal amyloid angiopathy

Cerebral amyloid angiopathy: an update

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

Probable cerebral amyloid angiopathy diagnosed on plain CT

Probable cerebral amyloid angiopathy diagnosed on plain CT

Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy

Retinal amyloid angiopathy

Cerebral amyloid angiopathy: an update

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery

Intravenous injection of beta-amyloid seeds promotes cerebral amyloid angiopathy (CAA)

Reduced vascular amyloid burden at microhemorrhage sites in cerebral amyloid angiopathy

Probable cerebral amyloid angiopathy diagnosed on plain CT

Probable cerebral amyloid angiopathy diagnosed on plain CT

Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy

A case of cerebral amyloid angiopathy with ipsilateral tau and contralateral amyloid PET uptake related to cadaveric dura mater implanted in childhood

Amyloid-beta antibody binding to cerebral amyloid angiopathy fibrils and risk for amyloid-related imaging abnormalities

The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets

Distinctive Clinical Effects of Haemorrhagic Markers in Cerebral Amyloid Angiopathy

Related objects

Reset password